A suit accusing Wyeth Inc. and Teva Pharmaceuticals of scheming to inflate the price of antidepressant Effexor XR, which already ascended once to the Third Circuit, remains largely intact on remand after a federal judge in New Jersey ruled on a series of defense motions to dismiss.

U.S. District Judge Peter Sheridan denied a motion to dismiss the case in its entirety. He granted several motions to dismiss various state-law claims, but most of those claims were dismissed without prejudice, allowing plaintiffs a chance to correct various deficiencies in their pleadings.